Edition:
United States

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

68.60CHF
11:30am EDT
Change (% chg)

CHF0.35 (+0.51%)
Prev Close
CHF68.25
Open
CHF68.25
Day's High
CHF68.95
Day's Low
CHF68.05
Volume
86,808
Avg. Vol
82,854
52-wk High
CHF74.00
52-wk Low
CHF58.15

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.15
Market Cap(Mil.): CHF3,776.64
Shares Outstanding(Mil.): 55.40
Dividend: 3.30
Yield (%): 4.84

Financials

  BION.S Industry Sector
P/E (TTM): 11.07 214.53 33.05
EPS (TTM): 6.16 -- --
ROI: 10.32 -3.67 13.17
ROE: 10.32 -5.61 15.10

BRIEF-BB Biotech Q2 Net Result Swings To Loss Of CHF 98 Mln

* Q2 NET LOSS OF CHF 98 MN. VERSUS NET PROFIT OF CHF 103 MN REPORTED FOR Q2 OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

1:04am EDT

BRIEF-BB Biotech H1 Loss At Around CHF 70 Mln

* H1 LOSS OF AROUND CHF 70 MLN (CHF 478.4 MLN PROFIT IN CORRESPONDING PERIOD OF PREVIOUS YEAR) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 12 2018

BRIEF-BB Biotech Q1 Profit Of CHF 28 Mln

* DGAP-ADHOC: BB BIOTECH SHARE GAINS VALUE IN FIRST QUARTER 2018 - SEVERAL LARGE-CAP BIOTECH COMPANIES TRADING AT WELL BELOW FUNDAMENTAL VALUE

Apr 20 2018

BRIEF-BB Biotech FY Net Result Turns to Profit Of CHF 688 Million

* FY NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN IN PREVIOUS PERIOD

Feb 16 2018

Earnings vs. Estimates